血清脂肪酸结合蛋白4水平升高预测腹腔透析患者的全因和心血管死亡率:一项为期五年的研究
Sijia Zhou1, Xiaoxiao Wang2, Qingfeng Han1
1Department of Nephrology, Peking University Third Hospital, Beijing, China.
Renal failure
|October 2, 2023
概括
血清脂肪酸结合蛋白4 (FABP4) 是腹腔透析 (PD) 患者死亡率的重要预测因素. 较高的FABP4水平独立地与所有原因和心血管死亡的风险增加有关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物标志物 生物标志物
- 心血管健康 心血管健康
背景情况:
- 腹腔透析 (PD) 是末期病的重要治疗方法.
- 确定可靠的生物标志物来预测PD患者的结果至关重要.
- 血清脂肪酸结合蛋白4 (FABP4) 是正在研究中的潜在标记物.
研究的目的:
- 调查血清FABP4在预测PD患者死亡率方面的潜在作用.
- 探索血清FABP4水平与PD中的临床/生化参数之间的关联.
主要方法:
- 一项前性观察性研究包括159名PD患者.
- 使用ELISA测量血清FABP4;评估身体组成和血管化.
- 收集了包括hs-CRP和iPTH在内的临床和生化数据.
主要成果:
- 血清FABP4升高与血管化增加相关,透析持续时间较长,BMI,hs-CRP,iPTH和甘油三水平较高.
- 较高的FABP4与减少的残留功能 (Kt/V尿素) 有关.
- 在PD患者中,血清FABP4独立预测了全因 (HR 1.003) 和心血管死亡 (HR 1.005).
结论:
- 血清FABP4水平升高是PD患者死亡率的独立预测因素.
- 在这个人群中,FABP4可能代表心血管事件和整体存活率的宝贵预后生物标志物.
相关概念视频
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
26
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
26
Peritoneal Dialysis III: Nursing Management
31
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
31
Ultrasound II: Endoscopic Ultrasound and FibroScan
135
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
135
Blood Studies for Cardiovascular System III: Serum Lipid Profile
179
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
179
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
110
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
Factors Affecting Protein-Drug Binding: Patient-Related Factors
73
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
73


